Campbell John Jette 4

What Happened

John Jette, a director of Kewaunee Scientific Corp. (KEQU), was awarded 2,013 shares on 2026-05-01. The Form 4 reports the shares as acquired at $0.00 (aggregate reported value $0) under transaction code "A" (award/grant). This was an equity award as part of compensation rather than an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-05-01 — 2,013 shares acquired at $0.00 per share (reported aggregate value $0).
• Transaction type/code: A (Grant/Award).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Shares were awarded under the company’s 2023 Omnibus Incentive Plan as the equity portion of the reporting person’s annual compensation (Footnote F1).
• Filing date and timeliness: Form filed 2026-05-04; this appears to be within the SEC’s two-business-day reporting window for Form 4s (i.e., the filing appears timely).

Context

This was a compensation-related equity award, common for executives and directors. Such awards do not necessarily indicate the insider’s view on the stock; they are typically part of regular pay and may be subject to vesting or other restrictions (the filing excerpt does not detail vesting). For investors tracking insider activity, outright purchases often carry more direct informational value than routine compensation awards.